The global leader in USAN/INN naming, partnering on 76% of USAN and 78% of INN drug name approvals!

367
Healthcare Clients
3198
Total Healthcare Names
121
Hematology Names
CLIENTNAMECATEGORY
SANGAMO THERAPEUTICSadlinacogene civaparvovecHematology
PORTOLAandexanet alfaHematology
SHIRE PHARMACEUTICALSapadamtase alfaHematology
EISAIavatrombopagHematology
EISAIavatrombopag maleateHematology
BLUEBIRD BIObetibeglogene darolentivecHematology
NOVARTIScrizanlizumabHematology
Catalystdalcinonacog alfaHematology
ACHILLIONdanicopanHematology
APOPHARMAdeferiproneHematology
GENEXINEefepoetin alfaHematology
GENEXINEeflenograstim alfaHematology
ARCHEMIXegaptivon pegolHematology
NOVIMMUNEemapalumabHematology
GENENTECHemicizumabHematology
ROCHEemicizumabHematology
JAPAN TOBACCOenarodustatHematology
PFIZEReribaxabanHematology
UNIQUREetranacogene dezaparvovecHematology
Pfizerfidanacogene elaparvovecHematology
PFIZERfidanacogene elaparvovecHematology
SANGAMO THERAPEUTICSinlezifigene civaparvovecHematology
UNIQURE BIOPHARMAlanacogene vosiparvovecHematology
YM BIOSCIENCESmomelotinibHematology
SHIRE PHARMACEUTICALSnonacog gammaHematology
BAYERoreptacog alfaHematology
ApellispegcetacoplanHematology
AFFYMAXpeginesatideHematology
SANGAMO THERAPEUTICSranuzifigene civaparvovecHematology
PFIZERrivipanselHematology
PFIZERrivipansel sodiumHematology
SHIRE PHARMACEUTICALSrurioctocog alfa pegolHematology
JOHNSON & JOHNSONsenicapocHematology
SHIRE PHARMACEUTICALSsusoctocog alfaHematology
BIOMARINvaloctocogene roxaparvovecHematology
SHIRE PHARMACEUTICALSvonicog alfaHematology
GLOBAL BLOOD THERAPEUTICSvoxelotorHematology
RazilucoplanHematology